CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.

The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.

Source:

https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2

UnitedHealthcare Expands Multiple Genetic and Molecular Policies

UnitedHealthcare (UHC) Community Plan’s August policy update revised several medical policies to reflect phase 2 of the DEX® Z-Code requirement for...

CMS Launches IDR Gateway: What Providers Need to Know Before September 15

In late 2026, the Federal Independent Dispute Resolution (IDR) process will transition from single-use web forms to the new IDR Gateway, which will...

Organizations Representing Clinical Labs and Diagnostics Write in Support of Legislation to Improve Medicare LCD Process

A coalition of more than 30 stakeholder organizations has written to key lawmakers expressing their support for the Timely Access to Coverage...